Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Nuvation Bio Inc. (NUVB) had Return on Tangible Equity of -123.69% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$7.87M |
|
$-567.94M |
|
$7.08M |
|
$0.80M |
|
$600.50M |
|
$-592.63M |
|
$24.69M |
|
$-567.94M |
|
$-567.94M |
|
$-567.94M |
|
$-567.94M |
|
$-567.94M |
|
$-567.94M |
|
$-592.63M |
|
$-591.94M |
|
268.77M |
|
268.77M |
|
$-2.11 |
|
$-2.11 |
|
| Balance Sheet Financials | |
$526.25M |
|
$0.59M |
|
$14.37M |
|
$540.63M |
|
$58.24M |
|
-- |
|
$18.59M |
|
$76.84M |
|
$463.79M |
|
$459.17M |
|
$463.79M |
|
337.84M |
|
| Cash Flow Statement Financials | |
$-130.41M |
|
$122.70M |
|
$0.33M |
|
$42.65M |
|
$35.72M |
|
$-6.93M |
|
$32.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.04 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
10.10% |
|
-7527.33% |
|
-7527.33% |
|
-7518.66% |
|
-7213.76% |
|
-7213.76% |
|
$-130.57M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.48 |
|
755.31 |
|
-122.46% |
|
|
Return on Tangible Equity |
-123.69% |
-105.05% |
|
-122.46% |
|
$1.37 |
|
$-0.49 |
|
$-0.49 |
|